Research Perspective Volume 11, Issue 19 pp 8048—8067
Rapamycin for longevity: opinion article
- 1 Cell Stress Biology Roswell Park Cancer Institute, Buffalo, NY 14263, USA
received: August 5, 2019 ; accepted: October 3, 2019 ; published: October 4, 2019 ;https://doi.org/10.18632/aging.102355
How to Cite
Copyright © 2019 Blagosklonny et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
From the dawn of civilization, humanity has dreamed of immortality. So why didn’t the discovery of the anti-aging properties of mTOR inhibitors change the world forever? I will discuss several reasons, including fear of the actual and fictional side effects of rapamycin, everolimus and other clinically-approved drugs, arguing that no real side effects preclude their use as anti-aging drugs today. Furthermore, the alternative to the reversible (and avoidable) side effects of rapamycin/everolimus are the irreversible (and inevitable) effects of aging: cancer, stroke, infarction, blindness and premature death. I will also discuss why it is more dangerous not to use anti-aging drugs than to use them and how rapamycin-based drug combinations have already been implemented for potential life extension in humans. If you read this article from the very beginning to its end, you may realize that the time is now.